CHITOSAN based WOUND MANAGEMENT SOLUTIONS Bioactive Microfibre Gelling (BMGTM) Technology Axio is a leading med-tech company focused on developing and manufacturing biomaterial-based medical devices. Our mission is to improve patient outcomes through advanced wound care and instant bleeding control using patented technologies with novel biopolymer, Chitosan. Our organization complies with ISO 13485:2016 and 21 CFR part 820 (QSR) standards, ensuring that our products are manufactured in a state-of-the-art facility and available in 50+ countries. For management of moderate to heavily exudating chronic and acute wounds | To control minor bleeding in superficial wounds | Management of post - debridement wounds | Infected wounds or wounds in which there is an increased risk of infection Available Sizes: MaxioCel transforms into cohesive gel matrix on contact with wound exudates and locks it in. Micro-contouring, leaving no dead space for microorganisms to grow and helps in bacterial sequestration and biofilm removal. MaxioCel® Chitosan Wound Dressing MaxioCel® Wound Irrigation Solution Accelerated granulation, re-epithelialisation. Painless and one piece removal Reduces dressing change cycles due to maximum absorbency 2.3x the absorbency of CMC-Ag extra Our published case studies on MaxioCel 1. Kulkarni M, Deshpande S, Lokapure S. Use of chitosan-based dressings for the management of a chronic lower limb ulcer: a case report. Wounds: a Compendium of Clinical Research and Practice. 2022 Feb 1;34(2):E13-6. | 2. Gupta AK, Vyas A. Use of chitosan wound dressing for the treatment of surgical site infection: a case report. Journal of Wound Care. 2023 Mar 1;32(Sup3):S4-8. | 3. Tickle J. Evaluation of a chitosan dressing in the management of hard-to-heal wounds. British Journal of Nursing. 2023 Feb 23;32(4):S44-50. | 4. Nair HK. Evaluation of a novel chitosan wound healing dressing based on bioactive microfibre gelling (bmg) technologyTM: a case series. Wounds Asia. 2022;5(3):1–23. Scientific literature evidence on chitosan based wound dressing 1. Patrulea V, Ostafe V, Borchard G, Jordan O. Chitosan as a starting material for wound healing applications. European Journal of Pharmaceutics and Biopharmaceutics. 2015 Nov 1;97:417-26. | 2. Dai T, Tanaka M, Huang YY, Hamblin MR. Chitosan preparations for wounds and burns: antimicrobial and wound-healing effects. Expert review of anti-infective therapy. 2011 Jul 1;9(7):857-79. | 3. Feng P, Luo Y, Ke C, Qiu H, Wang W, Zhu Y, Hou R, Xu L, Wu S. Chitosan-based functional materials for skin wound repair: Mechanisms and applications. Frontiers in Bioengineering and Biotechnology. 2021 Feb 18;9:650598. | 4. Matica MA, Aachmann FL, Tøndervik A, Sletta H, Ostafe V. Chitosan as a wound dressing starting material: Antimicrobial properties and mode of action. International journal of molecular sciences. 2019 Nov 24;20(23):5889. | 5. Ahmed S, Ikram S. Chitosan based scaffolds and their applications in wound healing. Achievements in the life sciences. 2016 Jun 1;10(1):27-37. Axio Biosolutions Private Limited Plot 18, Gujarat Pharma Techno Park, Sari- Matoda, TA: Sanand, Ahmedabad,Gujarat, India. Pin 382220 +91 88607 86067 *References: Axio Biosolutions Data on file DIABETIC FOOT ULCER | BURN INJURY |

ADVANCED WOUND BED PREPARATION THE NEXT GENERATION WOUND CARE DRESSING ing lfort d Hea l e m Comeeictf o imun ive W c Pa n E tMax crobiial Rff rt Ac tomati nd Hea fo g pAntim mum Comlin Sym MaWou xi ctive A sing Clean tion ina contamdement De Debri Facilitates gentle dressing removal Accelerated granulation, Accelerates granulation, re-epithiliazation Re-epithelialisation Biofilm prevention oist nds M ion Wou p the p Granulat Kee d u film Spee revents bio P Pain Management Pain management Exudate management *References: Axio Biosolutions Data on file Provides microbial barrier Wound Moisture Balance...